PETRA PHARMA CORP has a total of 11 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Canada, China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are RAVENNA PHARMACEUTICALS INC, HANGZHOU HUADONG MEDICINE GROUP BIOLOGY ENG RES CO LTD and MAGGIONI WINTHROP SPA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 3 | |
#2 | China | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kesicki Edward A | 11 |
#2 | Dahlgren Markus K | 9 |
#3 | Viklund Jenny | 9 |
#4 | Gerasyuto Aleksey I | 9 |
#5 | Persson Lars Boukharta | 9 |
#6 | Hickey Eugene R | 9 |
#7 | Forsblom Rickard | 6 |
#8 | Ginman Tobias | 6 |
#9 | Lindstrom Johan | 6 |
#10 | Lindström Johan | 3 |
Publication | Filing date | Title |
---|---|---|
US2020392162A1 | Chromenopyrimidine derivatives as phosphatidylinsitol phosphate kinase inhibitors | |
CN112020500A | Aminopyridine derivatives as inhibitors of phosphatidylinositol phosphokinase | |
CN112088157A | Aryl-bipyridine amine derivatives as phosphoinositide kinase inhibitors |